GlaxoSmithKline (GSK.L) News and Pharmaceutical & Healthcare Updates
50.67
1.4800
2.84 %
At close
06/18
USD
Daily range
50.44
51.91
51.91
Weekly range
50.44
53.39
53.39
GSK stock trades up amid rebound from session lows
GSK plc (GSK) stock is trading at GBX1,940.5, up 1.25% on the day. The price sits below its short- and medium-term moving averages but remains positioned above ...
GSK shares dip amid rising selling pressure
GSK plc (GSK) is trading at GBX 1,923.50, marking a decrease of 2.48% for the day. The stock currently sits just above its 20-day and 200-day moving averages, but has slipped below the 50-day ...
GSK shares dip amid rising selling pressure
GSK plc (GSK) is trading at GBX 1,923.50, marking a decrease of 2.48% for the day. The stock currently sits just above its 20-day and 200-day moving averages, but has slipped below the 50-day ...
Trading above key averages helps GSK stock maintain flat performance
GSK plc (GSK) stock is trading at GBX1,973.00, up 0.03% on the day and gapping higher by 3.5 GBX. The price sits above its key moving averages, maintaining a firm ...
GSK stock price forecast: GBX1,860.98 support holds as GSK trades flat
GSK plc (GSK) stock is trading at GBX1,941.50, down 0.44% on the session and approaching the lower end of today7s range. The price remains beneath key short- and ...
GBX1,900.01 support underpins GSK stock in subdued session
GSK plc (GSK) stock is trading at GBX1,953.00, down 0.26% on the day. The price is currently below its short-term moving average while remaining above medium- and ...
Resilient upward trend supports GSK stock despite limited movement
GSK plc (GSK) stock is trading at GBX1,979.50, marking a daily loss of 0.23%. The price remains positioned above its key moving averages, suggesting ongoing resilience ...
GSK makes $10.6bn cancer bet with Nuvalent acquisition
Six months into Luke Miels’s tenure as GSK chief executive, the UK drugmaker is making its largest biotech acquisition in more than 25 years with a $10.6bn deal for U.S. cancer group Nuvalent. ...
Why is GSK stock up today?
GSK plc (GSK) is currently trading at GBX 2,003.80, rising by 2.10% since the previous session. The share price stands above the 20-day (GBX 1,898.03), 50-day (GBX 1,978.09), and 200-day (GBX ...
GSK stock price forecast: GBX2,045.93 resistance as GSK ticks up 1.20%
GSK plc (GSK) stock is trading at GBX1,986.00, showing a daily gain of 1.20%. The price is above its key moving averages, reflecting short-term upward ...
Why is GSK stock up today?
GSK plc (GSK) is trading at GBX1,962.50, up GBX41.00 or 2.13% on the day. The share price stands above both the 20-day and 200-day moving averages, while remaining slightly below the 50-day moving ...
GSK stock consolidates as late-stage FDA-reviewed lung cancer treatments added
GSK plc (GSK) stock is trading at GBX1,935.50, up 0.73% on the day. The price action remains above its key moving averages, reflecting continued ...
Steady price for GSK stock as price holds in GBX1,871.87–GBX1,963.13 range
GSK plc (GSK) stock is trading at GBX1,917.50 after rising 0.74% on the day. The stock holds above its key short-, medium-, and long-term moving averages, reflecting ...
-2.85% for GSK stock as price action stays near daily low
GSK plc (GSK) stock is trading at GBX1,858.50 after a daily decrease of 2.85%. The stock is currently positioned below its key moving ...
Selling pressure pushes GSK stock lower in today's trading
GSK plc (GSK) is trading at GBX1,861.50, down 2.69% on the day. The asset continues to trade below the 20-day (GBX1,889.75) and 50-day (GBX1,985.34) moving averages, but remains above the 200-day ...
GSK weighs Nuvalent acquisition in potential $9 billion-plus oncology deal
Biotech dealmaking is accelerating in 2026 as large drugmakers seek to replenish pipelines and add new growth assets. Against that backdrop, GSK is in talks to buy cancer drugmaker Nuvalent for ...
GSK stock consolidates as price holds above GBX1,892.25 support
GSK plc (GSK) stock is trading at GBX1,921.50, down 0.85% for the day and moving close to the session's low. The price remains above its key moving averages in the ...
GSK stock consolidates as rally holds above layered support levels
GSK plc (GSK) stock is trading at GBX1,911.50, up 0.5% on the session. The price remains above its key moving averages, suggesting near-term momentum persists after an ...
What is behind GSK stock's recent gain in value today
GSK plc (GSK) is currently trading at GBX1,889.00, above the 20-day moving average (GBX1,880.93), below the 50-day (GBX1,987.57), and above the 200-day (GBX1,839.83). This highlights short-term ...
UK FTSE 100 slides as banks and energy stocks weigh on index
London equities remain under pressure on Thursday as heavyweight financial and energy names pull the FTSE 100 to its lowest level in more than two weeks. Losses deepen after weakness in ...
Flat trading for GSK stock as GBX1,918.04 resistance caps advances
GSK plc (GSK) stock is trading at GBX1,867.50, closing up 0.86% on the day. The price remains above its key short-term and long-term moving ...
